| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | IMPG1 LAMA2 PAPLN SSPOP THBS2 PXDN HMCN2 CCN1 SPON1 BMPER MUC5AC NPNT | 2.74e-08 | 188 | 155 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 PADI4 PAMR1 PCDHA11 LRP1B ADGRL4 COLEC11 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 C1R LTBP3 VWA2 NOTCH4 NPNT | 3.57e-07 | 749 | 155 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | NHLRC1 VPS11 RNF186 JADE2 DTX1 RNF185 RNF25 RNF114 NFX1 LONRF2 MED27 | 1.60e-04 | 372 | 155 | 11 | GO:0061630 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.95e-04 | 15 | 155 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | NHLRC1 VPS11 RNF186 JADE2 DTX1 RNF185 RNF25 RNF114 NFX1 LONRF2 MED27 | 2.86e-04 | 398 | 155 | 11 | GO:0061659 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | IMPG1 LAMA2 PAPLN SSPOP FREM1 TGFB1I1 THBS2 PXDN HMCN2 CCN1 SPON1 LTBP3 BMPER PLG VWA2 NPNT | 1.67e-06 | 530 | 152 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 3.11e-06 | 122 | 152 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | IMPG1 LAMA2 PAPLN SSPOP FREM1 TGFB1I1 THBS2 PXDN HMCN2 CCN1 SPON1 LTBP3 BMPER PLG VWA2 MUC5AC NPNT | 6.03e-06 | 656 | 152 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | IMPG1 LAMA2 PAPLN SSPOP FREM1 TGFB1I1 THBS2 PXDN HMCN2 CCN1 SPON1 LTBP3 BMPER PLG VWA2 MUC5AC NPNT | 6.28e-06 | 658 | 152 | 17 | GO:0030312 |
| HumanPheno | Duodenal ulcer | 4.50e-06 | 12 | 52 | 4 | HP:0002588 | |
| Domain | EGF-like_Ca-bd_dom | FAT4 PAMR1 LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 VWA2 NOTCH4 NPNT | 5.10e-19 | 124 | 155 | 19 | IPR001881 |
| Domain | EGF_CA | FAT4 PAMR1 LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 C1R LTBP3 VWA2 NOTCH4 NPNT | 9.12e-18 | 122 | 155 | 18 | SM00179 |
| Domain | EGF-like_dom | FAT4 IMPG1 PAMR1 LAMA2 LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 C6 VWA2 NOTCH4 NPNT | 1.31e-16 | 249 | 155 | 22 | IPR000742 |
| Domain | EGF_2 | FAT4 PAMR1 LAMA2 SSPOP LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 C6 VWA2 NOTCH4 NPNT | 4.90e-16 | 265 | 155 | 22 | PS01186 |
| Domain | EGF_3 | FAT4 PAMR1 SSPOP LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 C6 VWA2 NOTCH4 NPNT | 5.38e-16 | 235 | 155 | 21 | PS50026 |
| Domain | EGF_1 | FAT4 PAMR1 LAMA2 SSPOP LRP1B THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 C6 VWA2 NOTCH4 NPNT | 2.80e-15 | 255 | 155 | 21 | PS00022 |
| Domain | EGF-like_CS | FAT4 PAMR1 LAMA2 LRP1B ADGRL4 THBS2 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 C6 VWA2 NOTCH4 NPNT | 4.47e-15 | 261 | 155 | 21 | IPR013032 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FAT4 LRP1B ADGRL4 CELSR1 HMCN2 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 C1R LTBP3 NOTCH4 NPNT | 1.04e-14 | 106 | 155 | 15 | IPR000152 |
| Domain | EGF_CA | FAT4 LRP1B ADGRL4 HMCN2 EGF TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 NOTCH4 NPNT | 8.40e-14 | 99 | 155 | 14 | PS01187 |
| Domain | EGF | FAT4 PAMR1 LAMA2 LRP1B ADGRL4 THBS2 CELSR1 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 C1R LTBP3 VWA2 NOTCH4 NPNT | 8.96e-14 | 235 | 155 | 19 | SM00181 |
| Domain | EGF_Ca-bd_CS | FAT4 LRP1B ADGRL4 HMCN2 EGF TLL1 SLIT1 LRP1 DLK2 C1R LTBP3 NOTCH4 NPNT | 1.36e-12 | 97 | 155 | 13 | IPR018097 |
| Domain | ASX_HYDROXYL | FAT4 LRP1B ADGRL4 CELSR1 HMCN2 EGF CELSR2 LRP1 DLK2 C1R LTBP3 NOTCH4 NPNT | 2.03e-12 | 100 | 155 | 13 | PS00010 |
| Domain | EGF_CA | FAT4 LRP1B ADGRL4 THBS2 HMCN2 EGF TLL1 LRP1 C1R LTBP3 NOTCH4 NPNT | 6.26e-12 | 86 | 155 | 12 | PF07645 |
| Domain | EGF | PAMR1 LRP1B THBS2 CELSR1 EGF CELSR2 TLL1 SLIT1 LRP1 DLK2 LRP5 VWA2 NOTCH4 | 4.06e-11 | 126 | 155 | 13 | PF00008 |
| Domain | Growth_fac_rcpt_ | FAT4 KRT83 LRP1B CELSR1 HMCN2 EGF CELSR2 CCN1 SLIT1 LRP1 LTBP3 NOTCH4 NPNT | 5.98e-10 | 156 | 155 | 13 | IPR009030 |
| Domain | hEGF | 9.60e-08 | 28 | 155 | 6 | PF12661 | |
| Domain | VWFC_1 | 4.70e-07 | 36 | 155 | 6 | PS01208 | |
| Domain | VWFC_2 | 6.57e-07 | 38 | 155 | 6 | PS50184 | |
| Domain | VWC | 6.57e-07 | 38 | 155 | 6 | SM00214 | |
| Domain | TSP_1 | 8.87e-07 | 63 | 155 | 7 | PF00090 | |
| Domain | LDLR_class-A_CS | 9.01e-07 | 40 | 155 | 6 | IPR023415 | |
| Domain | TSP1 | 1.10e-06 | 65 | 155 | 7 | SM00209 | |
| Domain | TSP1_rpt | 1.10e-06 | 65 | 155 | 7 | IPR000884 | |
| Domain | TSP1 | 1.10e-06 | 65 | 155 | 7 | PS50092 | |
| Domain | VWF_dom | 1.22e-06 | 42 | 155 | 6 | IPR001007 | |
| Domain | GAIN_dom_N | 1.44e-06 | 11 | 155 | 4 | IPR032471 | |
| Domain | GAIN | 1.44e-06 | 11 | 155 | 4 | PF16489 | |
| Domain | Ldl_recept_a | 1.85e-06 | 45 | 155 | 6 | PF00057 | |
| Domain | LDLRA_1 | 2.73e-06 | 48 | 155 | 6 | PS01209 | |
| Domain | CUB | 3.09e-06 | 49 | 155 | 6 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 3.09e-06 | 49 | 155 | 6 | IPR002172 | |
| Domain | LDLa | 3.09e-06 | 49 | 155 | 6 | SM00192 | |
| Domain | LDLRA_2 | 3.09e-06 | 49 | 155 | 6 | PS50068 | |
| Domain | VWC | 3.11e-06 | 28 | 155 | 5 | PF00093 | |
| Domain | CUB | 3.49e-06 | 50 | 155 | 6 | SM00042 | |
| Domain | Ldl_recept_b | 4.28e-06 | 14 | 155 | 4 | PF00058 | |
| Domain | LDLRB | 4.28e-06 | 14 | 155 | 4 | PS51120 | |
| Domain | - | 4.40e-06 | 52 | 155 | 6 | 2.60.120.290 | |
| Domain | CUB | 4.93e-06 | 53 | 155 | 6 | PS01180 | |
| Domain | - | NHLRC1 RNF224 VPS11 RNF186 BRPF3 KMT2B PHF19 JADE2 NSD2 DTX1 RNF185 RNF25 RNF114 TRAF4 LONRF2 | 5.16e-06 | 449 | 155 | 15 | 3.30.40.10 |
| Domain | LY | 5.80e-06 | 15 | 155 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.80e-06 | 15 | 155 | 4 | IPR000033 | |
| Domain | Znf_RING/FYVE/PHD | NHLRC1 RNF224 VPS11 RNF186 BRPF3 KMT2B PHF19 JADE2 NSD2 DTX1 RNF185 RNF25 RNF114 TRAF4 LONRF2 | 6.72e-06 | 459 | 155 | 15 | IPR013083 |
| Domain | CUB_dom | 7.59e-06 | 57 | 155 | 6 | IPR000859 | |
| Domain | Laminin_G | 8.41e-06 | 58 | 155 | 6 | IPR001791 | |
| Domain | RING | NHLRC1 RNF224 VPS11 RNF186 NSD2 DTX1 RNF185 RNF25 RNF114 TRAF4 NFX1 LONRF2 | 9.39e-06 | 305 | 155 | 12 | SM00184 |
| Domain | CTCK_1 | 1.28e-05 | 18 | 155 | 4 | PS01185 | |
| Domain | LAM_G_DOMAIN | 1.48e-05 | 38 | 155 | 5 | PS50025 | |
| Domain | - | 1.69e-05 | 39 | 155 | 5 | 2.120.10.30 | |
| Domain | Znf_RING | NHLRC1 RNF224 VPS11 RNF186 NSD2 DTX1 RNF185 RNF25 RNF114 TRAF4 NFX1 LONRF2 | 1.83e-05 | 326 | 155 | 12 | IPR001841 |
| Domain | Laminin_G_2 | 1.92e-05 | 40 | 155 | 5 | PF02210 | |
| Domain | LamG | 3.09e-05 | 44 | 155 | 5 | SM00282 | |
| Domain | ZF_RING_1 | NHLRC1 RNF224 VPS11 RNF186 DTX1 RNF185 RNF25 RNF114 TRAF4 NFX1 LONRF2 | 3.23e-05 | 291 | 155 | 11 | PS00518 |
| Domain | 6-blade_b-propeller_TolB-like | 3.84e-05 | 46 | 155 | 5 | IPR011042 | |
| Domain | - | 3.84e-05 | 46 | 155 | 5 | 4.10.400.10 | |
| Domain | ZF_RING_2 | NHLRC1 RNF224 VPS11 RNF186 DTX1 RNF185 RNF25 RNF114 TRAF4 NFX1 LONRF2 | 4.01e-05 | 298 | 155 | 11 | PS50089 |
| Domain | Znf_PHD-finger | 5.00e-05 | 79 | 155 | 6 | IPR019787 | |
| Domain | Cys_knot_C | 5.04e-05 | 25 | 155 | 4 | IPR006207 | |
| Domain | CTCK_2 | 5.04e-05 | 25 | 155 | 4 | PS01225 | |
| Domain | DUF5050 | 6.84e-05 | 2 | 155 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.84e-05 | 2 | 155 | 2 | PF16472 | |
| Domain | Sushi | 7.00e-05 | 52 | 155 | 5 | PF00084 | |
| Domain | CCP | 8.41e-05 | 54 | 155 | 5 | SM00032 | |
| Domain | SUSHI | 1.00e-04 | 56 | 155 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.09e-04 | 57 | 155 | 5 | IPR000436 | |
| Domain | C8 | 1.17e-04 | 12 | 155 | 3 | PF08742 | |
| Domain | TIL | 1.17e-04 | 12 | 155 | 3 | PF01826 | |
| Domain | - | 1.40e-04 | 95 | 155 | 6 | 2.60.120.200 | |
| Domain | Unchr_dom_Cys-rich | 1.51e-04 | 13 | 155 | 3 | IPR014853 | |
| Domain | C8 | 1.51e-04 | 13 | 155 | 3 | SM00832 | |
| Domain | GPS | 1.74e-04 | 34 | 155 | 4 | SM00303 | |
| Domain | TIL_dom | 1.91e-04 | 14 | 155 | 3 | IPR002919 | |
| Domain | GPS | 1.96e-04 | 35 | 155 | 4 | PF01825 | |
| Domain | Zinc_finger_PHD-type_CS | 2.04e-04 | 65 | 155 | 5 | IPR019786 | |
| Domain | Znf_NFX1 | 2.04e-04 | 3 | 155 | 2 | IPR000967 | |
| Domain | ZnF_NFX | 2.04e-04 | 3 | 155 | 2 | SM00438 | |
| Domain | zf-NF-X1 | 2.04e-04 | 3 | 155 | 2 | PF01422 | |
| Domain | GPS | 2.19e-04 | 36 | 155 | 4 | PS50221 | |
| Domain | GPS | 2.43e-04 | 37 | 155 | 4 | IPR000203 | |
| Domain | VWF_type-D | 2.90e-04 | 16 | 155 | 3 | IPR001846 | |
| Domain | VWFD | 2.90e-04 | 16 | 155 | 3 | PS51233 | |
| Domain | VWD | 2.90e-04 | 16 | 155 | 3 | SM00216 | |
| Domain | VWD | 2.90e-04 | 16 | 155 | 3 | PF00094 | |
| Domain | PHD | 3.99e-04 | 75 | 155 | 5 | PF00628 | |
| Domain | Znf_RING_CS | 4.28e-04 | 163 | 155 | 7 | IPR017907 | |
| Domain | zf-C3HC4 | 5.58e-04 | 223 | 155 | 8 | PF00097 | |
| Domain | Vmron_rcpt_1 | 6.73e-04 | 5 | 155 | 2 | IPR004072 | |
| Domain | V1R | 6.73e-04 | 5 | 155 | 2 | PF03402 | |
| Domain | EPHD | 7.69e-04 | 22 | 155 | 3 | PS51805 | |
| Domain | CT | 7.69e-04 | 22 | 155 | 3 | SM00041 | |
| Domain | 7tm_2 | 7.81e-04 | 50 | 155 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 7.81e-04 | 50 | 155 | 4 | PS00650 | |
| Domain | PHD | 8.74e-04 | 89 | 155 | 5 | SM00249 | |
| Domain | Znf_PHD | 9.67e-04 | 91 | 155 | 5 | IPR001965 | |
| Domain | Znf_C2HC | 1.00e-03 | 6 | 155 | 2 | IPR002515 | |
| Domain | FAD-bd | 1.00e-03 | 6 | 155 | 2 | IPR002938 | |
| Domain | zf-C2HC | 1.00e-03 | 6 | 155 | 2 | PF01530 | |
| Domain | FAD_binding_3 | 1.00e-03 | 6 | 155 | 2 | PF01494 | |
| Domain | HormR | 1.13e-03 | 25 | 155 | 3 | SM00008 | |
| Domain | ZF_PHD_2 | 1.17e-03 | 95 | 155 | 5 | PS50016 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.38e-05 | 68 | 109 | 6 | M27303 | |
| Pathway | PID_TAP63_PATHWAY | 5.90e-05 | 54 | 109 | 5 | M256 | |
| Pathway | PID_NOTCH_PATHWAY | 9.05e-05 | 59 | 109 | 5 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.06e-04 | 61 | 109 | 5 | M39540 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.20e-04 | 143 | 109 | 7 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.98e-04 | 109 | 109 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.18e-04 | 111 | 109 | 6 | M27416 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.26e-04 | 39 | 109 | 4 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-04 | 39 | 109 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.26e-04 | 39 | 109 | 4 | MM15165 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN KMT2B KALRN NSD2 RTTN PER1 ADGRL1 PAPLN FAAP100 TRAF4 CELSR1 SYNE3 MDN1 CELSR2 ZNF827 SCN5A NFX1 LRP5 MICAL3 LTBP3 EP300 BAHCC1 | 6.73e-09 | 1105 | 158 | 22 | 35748872 |
| Pubmed | 4.49e-08 | 22 | 158 | 5 | 35245678 | ||
| Pubmed | 5.35e-08 | 75 | 158 | 7 | 20637190 | ||
| Pubmed | 7.95e-08 | 167 | 158 | 9 | 22159717 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 22401280 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.20e-06 | 248 | 158 | 9 | 24006456 | |
| Pubmed | BRPF3 AKAP17A NSD2 BTBD18 PER1 DICER1 ZNF768 PARS2 BCL11B HMCN2 ZNF827 NAT10 SCN5A LRP1 CSMD1 AGBL1 EP300 BAHCC1 | 3.56e-06 | 1116 | 158 | 18 | 31753913 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 20605778 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 28935710 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 24639464 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN RASA2 JADE2 NSD2 ADGRL1 SSPOP NEK9 PXDN ZNF827 SLC16A14 TLL1 NAT10 LRP1 LRP5 MICAL3 PRKD1 PAN3 CSMD1 MED27 EP300 | 1.49e-05 | 1489 | 158 | 20 | 28611215 |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.51e-05 | 33 | 158 | 4 | 25713288 | |
| Pubmed | 1.86e-05 | 71 | 158 | 5 | 33541421 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.05e-05 | 2 | 158 | 2 | 15963947 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25773758 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36376971 | ||
| Pubmed | Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells. | 2.05e-05 | 2 | 158 | 2 | 21994466 | |
| Pubmed | PHLPPing through history: a decade in the life of PHLPP phosphatases. | 2.05e-05 | 2 | 158 | 2 | 27913677 | |
| Pubmed | Ras-associating domain proteins: a new class of cyclic nucleotide-gated channel modulators. | 2.05e-05 | 2 | 158 | 2 | 22183406 | |
| Pubmed | LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation. | 2.05e-05 | 2 | 158 | 2 | 28596374 | |
| Pubmed | NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein. | 2.05e-05 | 2 | 158 | 2 | 33742125 | |
| Pubmed | STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. | 2.05e-05 | 2 | 158 | 2 | 15919823 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24892992 | ||
| Pubmed | Reduced level of epidermal growth factor in the skeletal muscle of mice with muscular dystrophy. | 2.05e-05 | 2 | 158 | 2 | 1577403 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18434322 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25793736 | ||
| Pubmed | Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis. | 2.05e-05 | 2 | 158 | 2 | 26187040 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28752190 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26057128 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23292348 | ||
| Pubmed | Molecular cloning of POEM: a novel adhesion molecule that interacts with alpha8beta1 integrin. | 2.05e-05 | 2 | 158 | 2 | 11546798 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17911590 | ||
| Pubmed | p21 deficiency is susceptible to osteoarthritis through STAT3 phosphorylation. | 2.05e-05 | 2 | 158 | 2 | 26546411 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 38602289 | ||
| Pubmed | 2.54e-05 | 13 | 158 | 3 | 39250533 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 2.54e-05 | 13 | 158 | 3 | 21900571 | |
| Pubmed | USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling. | 2.54e-05 | 13 | 158 | 3 | 28363942 | |
| Pubmed | 3.00e-05 | 130 | 158 | 6 | 12421765 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.12e-05 | 79 | 158 | 5 | 18757743 | |
| Pubmed | 3.23e-05 | 14 | 158 | 3 | 28232627 | ||
| Pubmed | Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. | 4.02e-05 | 15 | 158 | 3 | 20473291 | |
| Pubmed | 4.93e-05 | 16 | 158 | 3 | 36768434 | ||
| Pubmed | 5.40e-05 | 371 | 158 | 9 | 15747579 | ||
| Pubmed | ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination. | 5.97e-05 | 17 | 158 | 3 | 26581405 | |
| Pubmed | Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. | 5.97e-05 | 17 | 158 | 3 | 12023963 | |
| Pubmed | 5.97e-05 | 17 | 158 | 3 | 26740489 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 27636103 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 20610895 | ||
| Pubmed | PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells. | 6.13e-05 | 3 | 158 | 2 | 32294598 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 15649887 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 23846336 | ||
| Pubmed | A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland. | 6.13e-05 | 3 | 158 | 2 | 28041896 | |
| Pubmed | Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. | 6.13e-05 | 3 | 158 | 2 | 11773079 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 11677057 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 18263614 | ||
| Pubmed | p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. | 6.13e-05 | 3 | 158 | 2 | 19275888 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 34663797 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 23178160 | ||
| Pubmed | A HIC-5- and KLF4-dependent mechanism transactivates p21(Cip1) in response to anchorage loss. | 6.13e-05 | 3 | 158 | 2 | 23007394 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 17386267 | ||
| Pubmed | Co-activator SRC-1 is dispensable for transcriptional control by STAT3. | 6.13e-05 | 3 | 158 | 2 | 19203349 | |
| Pubmed | Barrier Function of the Repaired Skin Is Disrupted Following Arrest of Dicer in Keratinocytes. | 6.13e-05 | 3 | 158 | 2 | 25896246 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 31554859 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 12906867 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 25845235 | ||
| Pubmed | Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. | 6.13e-05 | 3 | 158 | 2 | 20513427 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 27760826 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 26965998 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 27468691 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 30779072 | ||
| Pubmed | The phosphatase PHLPP controls the cellular levels of protein kinase C. | 6.13e-05 | 3 | 158 | 2 | 18162466 | |
| Pubmed | Harnessing the anti-cancer natural product nimbolide for targeted protein degradation. | 6.13e-05 | 3 | 158 | 2 | 31209351 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 10764767 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 38182571 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 29233865 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 25269647 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 20472562 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 22264824 | ||
| Pubmed | Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma. | 6.13e-05 | 3 | 158 | 2 | 26245343 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 11470831 | ||
| Pubmed | MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation. | 6.13e-05 | 3 | 158 | 2 | 23601845 | |
| Pubmed | A LIM protein, Hic-5, functions as a potential coactivator for Sp1. | 6.13e-05 | 3 | 158 | 2 | 14755691 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 21926348 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 31122700 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 24945731 | ||
| Pubmed | Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. | 6.13e-05 | 3 | 158 | 2 | 34348155 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 23645206 | ||
| Pubmed | Snf2l regulates Foxg1-dependent progenitor cell expansion in the developing brain. | 7.14e-05 | 18 | 158 | 3 | 22516202 | |
| Pubmed | Neural Stem Cells Direct Axon Guidance via Their Radial Fiber Scaffold. | 7.14e-05 | 18 | 158 | 3 | 32707082 | |
| Pubmed | ECD NEK9 DICER1 PARS2 STAT3 CELSR1 MDN1 LRP1 MICAL3 DDX20 PRKD1 TBR1 | 7.58e-05 | 686 | 158 | 12 | 28380382 | |
| Pubmed | 8.45e-05 | 19 | 158 | 3 | 23968833 | ||
| Pubmed | miRNAs are Essential for the Survival and Maturation of Cortical Interneurons. | 8.45e-05 | 19 | 158 | 3 | 24451661 | |
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 8.45e-05 | 19 | 158 | 3 | 28916710 | |
| Pubmed | 1.09e-04 | 407 | 158 | 9 | 12693553 | ||
| Pubmed | 1.15e-04 | 21 | 158 | 3 | 26939553 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.15e-04 | 21 | 158 | 3 | 21337463 | |
| Pubmed | Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. | 1.15e-04 | 21 | 158 | 3 | 23637172 | |
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 7671825 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 39044282 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 19329556 | ||
| Interaction | C2CD4B interactions | 1.00e-06 | 44 | 154 | 6 | int:C2CD4B | |
| Interaction | NXPH2 interactions | 4.87e-06 | 33 | 154 | 5 | int:NXPH2 | |
| GeneFamily | PHD finger proteins | 1.91e-05 | 90 | 111 | 6 | 88 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.59e-05 | 57 | 111 | 5 | 1179 | |
| GeneFamily | Low density lipoprotein receptors | 6.16e-05 | 13 | 111 | 3 | 634 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.12e-04 | 3 | 111 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.12e-04 | 3 | 111 | 2 | 1189 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 2.22e-04 | 4 | 111 | 2 | 918 | |
| GeneFamily | Ring finger proteins | 2.96e-04 | 275 | 111 | 8 | 58 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.76e-04 | 161 | 111 | 6 | 593 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.31e-03 | 9 | 111 | 2 | 1263 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.71e-03 | 206 | 111 | 6 | 682 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 4.78e-03 | 17 | 111 | 2 | 701 | |
| GeneFamily | LIM domain containing | 5.70e-03 | 59 | 111 | 3 | 1218 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA2 PAPLN SSPOP IGSF10 THBS2 PXDN HMCN2 CCN1 SPON1 SLIT1 LTBP3 BMPER VWA2 NPNT | 1.13e-11 | 191 | 158 | 14 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMA2 PAPLN SSPOP IGSF10 THBS2 PXDN HMCN2 CCN1 SPON1 SLIT1 LTBP3 BMPER VWA2 NPNT | 1.60e-11 | 196 | 158 | 14 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | IMPG1 LAMA2 PAPLN SSPOP IGSF10 THBS2 PXDN HMCN2 CCN1 SPON1 SLIT1 LTBP3 BMPER VWA2 NPNT | 1.05e-10 | 270 | 158 | 15 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | IMPG1 LAMA2 PAPLN SSPOP IGSF10 THBS2 PXDN HMCN2 CCN1 SPON1 SLIT1 LTBP3 BMPER VWA2 NPNT | 1.35e-10 | 275 | 158 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | IMPG1 PAMR1 LAMA2 PAPLN SSPOP FREM1 IGSF10 COLEC11 THBS2 PXDN HMCN2 EGF CCN1 SPON1 TLL1 SLIT1 LTBP3 BMPER PLG VWA2 MUC5AC NPNT | 1.85e-07 | 1008 | 158 | 22 | MM17056 |
| Coexpression | NABA_MATRISOME | IMPG1 PAMR1 LAMA2 PAPLN SSPOP FREM1 IGSF10 COLEC11 THBS2 PXDN HMCN2 EGF CCN1 SPON1 TLL1 SLIT1 LTBP3 BMPER PLG VWA2 MUC5AC NPNT | 2.50e-07 | 1026 | 158 | 22 | M5889 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ABHD15 FAT4 THSD7B ECT2 ST6GALNAC2 ADRA2C SYNE3 OAF CCN1 GPR150 SPON1 TLL1 SCN5A HS3ST6 CPXM1 LRP5 TBR1 TNS3 L3MBTL4 NPNT | 7.72e-06 | 1074 | 158 | 20 | M1941 |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN | 3.03e-05 | 200 | 158 | 8 | M9055 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 3.08e-05 | 99 | 158 | 6 | M39152 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | CDKN1A VN1R5 PADI4 PER1 LAMA2 ADGRL4 IGSF10 MAGI2 PXDN CCN1 SPON1 PHLPP1 C1R LTBP3 TBR1 | 3.28e-05 | 721 | 158 | 15 | M1999 |
| Coexpression | PEREZ_TP53_TARGETS | CDKN1A ABHD15 KLHL28 KALRN ACO1 ZNFX1 BRINP1 DUS3L GASK1B ZNF786 TRAF4 SYNE3 CELSR2 SLC16A14 HS3ST6 LRP5 MICAL3 LTBP3 MUC5AC NPNT | 3.82e-05 | 1201 | 158 | 20 | M4391 |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 7.14e-05 | 115 | 158 | 6 | M40201 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | CDKN1A DENND2A LAMA2 ITGA1 GASK1B IGSF10 THBS2 PXDN OAF CCN1 SPON1 LRP1 CPXM1 C1R CSMD1 | 6.99e-07 | 445 | 151 | 15 | GSM777043_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SFMBT1 KLHL28 PHF19 CARMIL3 RNF25 PSD3 BRINP1 GASK1B ZNF786 STAT3 BCL11B NSUN3 NSMF BMPER LONRF2 ST18 PHLPP2 | 1.86e-06 | 614 | 151 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | PAMR1 LAMA2 ITGA1 IGSF10 THBS2 PXDN CCN1 SPON1 LRP1 CPXM1 C1R LTBP3 CSMD1 TNS3 | 6.32e-06 | 466 | 151 | 14 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | CDKN1A PAMR1 LAMA2 GASK1B IGSF10 THBS2 PXDN LRRN4CL CCN1 LRP1 CPXM1 C1R BMPER | 1.52e-05 | 437 | 151 | 13 | GSM777046_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 BCL11B NSUN3 NSMF TLL1 BMPER LONRF2 ST18 PHLPP2 | 1.57e-05 | 722 | 151 | 17 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF CELSR2 TLL1 BMPER LONRF2 ST18 PHLPP2 | 1.87e-05 | 732 | 151 | 17 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF TLL1 BMPER LONRF2 ST18 PHLPP2 | 1.91e-05 | 658 | 151 | 16 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 BCL11B NSUN3 NSMF TLL1 BMPER LONRF2 ST18 PHLPP2 | 2.42e-05 | 747 | 151 | 17 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF CELSR2 BMPER LONRF2 ST18 PHLPP2 | 3.00e-05 | 683 | 151 | 16 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FAT4 BRPF3 TMEM150A KMT2B PHF19 DTX1 PSD3 PER1 LAMA2 ADGRL1 BRINP1 FREM1 STAT3 IGSF10 THBS2 NSUN3 OAF ZNF827 ABCB8 LRP1 CPXM1 LONRF2 | 4.56e-05 | 1208 | 151 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | FAT4 PSD3 THSD7B FREM1 IGSF10 MAGI2 THBS2 CCN1 LRP1 PRKD1 TNS3 | 5.13e-05 | 357 | 151 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_100 | 5.83e-05 | 30 | 151 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | PSD3 LAMA2 THSD7B PAK6 ZNF786 ST6GALNAC2 IGSF10 THBS2 VPS13D BCL11B NSUN3 NSMF CELSR2 ABCB8 LTBP3 BMPER LONRF2 ST18 PARP12 | 6.34e-05 | 973 | 151 | 19 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | MICAL1 FAT4 DTX1 PSD3 LAMA2 ADGRL1 BRINP1 PAK6 NEK9 FREM1 TGFB1I1 IGSF10 THBS2 NSMF OAF TLL1 SLIT1 CPXM1 LTBP3 BMPER LONRF2 | 6.48e-05 | 1148 | 151 | 21 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | KLHL28 PHF19 CARMIL3 PSD3 BRINP1 GASK1B ZNF786 STAT3 BCL11B NSMF TLL1 BMPER LONRF2 ST18 PHLPP2 | 7.44e-05 | 659 | 151 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF CELSR2 BMPER LONRF2 ST18 PHLPP2 | 8.67e-05 | 747 | 151 | 16 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF BMPER LONRF2 ST18 PHLPP2 | 1.20e-04 | 688 | 151 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | SFMBT1 DENND2A PAMR1 KALRN BRINP1 THSD7B FREM1 ADGRL4 THBS2 CELSR1 SLC14A1 SPON1 TLL1 HS3ST6 CPXM1 BMPER PUS7L | 1.27e-04 | 855 | 151 | 17 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF BMPER LONRF2 ST18 PHLPP2 | 1.99e-04 | 721 | 151 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF BMPER LONRF2 ST18 PHLPP2 | 2.28e-04 | 730 | 151 | 15 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.40e-04 | 122 | 151 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | ABHD15 FAT4 LAMA2 NEK9 FREM1 IGSF10 VPS13D BCL11B OAF ZNF827 TLL1 ABCB8 CPXM1 TNS3 PARP12 | 2.42e-04 | 734 | 151 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | KLHL28 PHF19 CARMIL3 PSD3 ADGRL1 BRINP1 GASK1B ZNF786 STAT3 NSUN3 NSMF BMPER LONRF2 ST18 PHLPP2 | 2.75e-04 | 743 | 151 | 15 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | MICAL1 KLHL28 PCDHA11 POLR2M BRINP1 THSD7B ADGRL4 COLEC11 THBS2 OAF CCN1 SLC14A1 WDCP TLL1 CPXM1 BMPER | 3.15e-04 | 837 | 151 | 16 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | KLHL28 PHF19 CARMIL3 PSD3 BRINP1 STAT3 BCL11B NSMF PHLPP1 BMPER ST18 | 3.65e-04 | 447 | 151 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.73e-04 | 86 | 151 | 5 | GSM777055_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.93e-04 | 87 | 151 | 5 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | PAMR1 LAMA2 ITGA1 IGSF10 COLEC11 THBS2 PXDN CCN1 LRP1 CPXM1 C1R | 4.08e-04 | 453 | 151 | 11 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | PAMR1 ITGA1 IGSF10 THBS2 PXDN CCN1 SPON1 LRP1 CPXM1 C1R CSMD1 | 4.23e-04 | 455 | 151 | 11 | GSM777055_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | NHLRC1 RNF186 KLHL28 JADE2 BRINP1 TMC4 ST6GALNAC2 PLEK2 BCL11B NSUN3 SLC14A1 WDCP FER1L4 PSAPL1 NPNT | 4.58e-04 | 780 | 151 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 4.72e-04 | 388 | 151 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | DENND2A FAT4 KLHL28 PSD3 THSD7B GASK1B FREM1 IGSF10 MAGI2 SLC25A32 THBS2 CCN1 LRP1 PRKD1 TNS3 | 4.77e-04 | 783 | 151 | 15 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200 | 4.92e-04 | 22 | 151 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k1 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#1_top-relative-expression-ranked_500 | 4.92e-04 | 22 | 151 | 3 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.92e-04 | 255 | 151 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 5.09e-04 | 92 | 151 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DENND2A FAT4 KALRN PSD3 THSD7B GASK1B FREM1 IGSF10 MAGI2 THBS2 CCN1 LRP1 CPXM1 PRKD1 TNS3 | 5.73e-04 | 797 | 151 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | JADE2 PCDHA11 TMC4 PLEK2 CELSR1 BCL11B CCN1 TLL1 PSAPL1 VWA2 | 6.10e-04 | 401 | 151 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.48e-04 | 97 | 151 | 5 | GSM777043_100 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | DENND2A FAT4 PAMR1 LAMA2 FREM1 IGSF10 THBS2 OAF SPON1 CPXM1 C1R | 9.86e-11 | 193 | 157 | 11 | 9ab47b360bee1d4f1092c2269e58acebe9584021 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FAT4 PAMR1 LAMA2 ITGA1 TGFB1I1 THBS2 CCN1 SPON1 C1R BMPER NPNT | 1.04e-10 | 194 | 157 | 11 | 8fae8061b350336299aa81f378e07deadbd55123 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FAT4 PAMR1 LAMA2 ITGA1 TGFB1I1 THBS2 CCN1 SPON1 C1R BMPER NPNT | 1.04e-10 | 194 | 157 | 11 | 4d7d24390fdb379f943ddcc70a63f23955e10163 |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | PAMR1 LAMA2 IGSF10 THBS2 LRRN4CL OAF SPON1 SLIT1 LRP1 CPXM1 C1R | 1.44e-10 | 200 | 157 | 11 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.00e-10 | 175 | 157 | 10 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-09 | 191 | 157 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.72e-09 | 192 | 157 | 10 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-09 | 192 | 157 | 10 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-09 | 194 | 157 | 10 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PAMR1 LAMA2 ITGA1 TGFB1I1 THBS2 LRRN4CL SPON1 LRP1 CPXM1 C1R | 1.90e-09 | 194 | 157 | 10 | d3db241ea316bbcde6d16618193b474591ad5ce4 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A FAT4 KALRN LAMA2 ITGA1 CSMD3 FREM1 MAGI2 SPON1 BMPER | 1.90e-09 | 194 | 157 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PAMR1 LAMA2 ITGA1 TGFB1I1 THBS2 LRRN4CL SPON1 LRP1 CPXM1 C1R | 1.90e-09 | 194 | 157 | 10 | 29f83cdd63314fff41258937d70b881a5503bfcc |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-09 | 195 | 157 | 10 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-09 | 195 | 157 | 10 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-09 | 196 | 157 | 10 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-09 | 196 | 157 | 10 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-09 | 197 | 157 | 10 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A FAT4 KALRN LAMA2 ITGA1 FREM1 MAGI2 THBS2 SPON1 BMPER | 2.32e-09 | 198 | 157 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-09 | 200 | 157 | 10 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | PAMR1 LAMA2 IGSF10 COLEC11 THBS2 LRRN4CL OAF SPON1 CPXM1 C1R | 2.55e-09 | 200 | 157 | 10 | 0aa316b71f195ecf17ee897e307f8928a755a637 |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.80e-08 | 182 | 157 | 9 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-08 | 189 | 157 | 9 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-08 | 189 | 157 | 9 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-08 | 189 | 157 | 9 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-08 | 189 | 157 | 9 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-08 | 190 | 157 | 9 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.73e-08 | 191 | 157 | 9 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-08 | 192 | 157 | 9 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-08 | 192 | 157 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-08 | 192 | 157 | 9 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-08 | 192 | 157 | 9 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-08 | 192 | 157 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.86e-08 | 192 | 157 | 9 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-08 | 193 | 157 | 9 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-08 | 193 | 157 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-08 | 193 | 157 | 9 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.12e-08 | 194 | 157 | 9 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-08 | 194 | 157 | 9 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-08 | 194 | 157 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-08 | 194 | 157 | 9 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-08 | 196 | 157 | 9 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-08 | 196 | 157 | 9 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-08 | 196 | 157 | 9 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-08 | 196 | 157 | 9 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-08 | 197 | 157 | 9 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 3.72e-08 | 198 | 157 | 9 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | (5)_Fibroblast-F|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.89e-08 | 199 | 157 | 9 | 1f66db4f502de4a5159cde90fcb3befb26b8d375 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.89e-08 | 199 | 157 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-08 | 200 | 157 | 9 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-08 | 200 | 157 | 9 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-08 | 200 | 157 | 9 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-08 | 200 | 157 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-08 | 200 | 157 | 9 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-08 | 200 | 157 | 9 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.06e-08 | 200 | 157 | 9 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-08 | 200 | 157 | 9 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-08 | 200 | 157 | 9 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | distal-1-mesenchymal-Adventitial_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-08 | 200 | 157 | 9 | 738060ed65fa5473fdb39e686f7cdecc059ed92c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-08 | 200 | 157 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 4.06e-08 | 200 | 157 | 9 | ee3d06865a6300e1279edf6664320b71647f5efb | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-08 | 200 | 157 | 9 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-07 | 176 | 157 | 8 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-07 | 176 | 157 | 8 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.27e-07 | 177 | 157 | 8 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 180 | 157 | 8 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 180 | 157 | 8 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-07 | 181 | 157 | 8 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-07 | 181 | 157 | 8 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-07 | 181 | 157 | 8 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-07 | 181 | 157 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-07 | 183 | 157 | 8 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-07 | 185 | 157 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.18e-07 | 185 | 157 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-07 | 185 | 157 | 8 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-07 | 186 | 157 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-07 | 186 | 157 | 8 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 187 | 157 | 8 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.60e-07 | 188 | 157 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-07 | 189 | 157 | 8 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.74e-07 | 189 | 157 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.90e-07 | 190 | 157 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-07 | 190 | 157 | 8 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-07 | 191 | 157 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-07 | 191 | 157 | 8 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-07 | 191 | 157 | 8 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-07 | 191 | 157 | 8 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 191 | 157 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-07 | 191 | 157 | 8 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 191 | 157 | 8 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 191 | 157 | 8 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 191 | 157 | 8 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-07 | 191 | 157 | 8 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 191 | 157 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-07 | 191 | 157 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.22e-07 | 192 | 157 | 8 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-07 | 192 | 157 | 8 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-07 | 192 | 157 | 8 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.36e-05 | 28 | 155 | 4 | DOID:1094 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 2.06e-05 | 31 | 155 | 4 | EFO_0010820 | |
| Disease | neuroticism measurement, cognitive function measurement | KALRN JADE2 PCDHA11 BRINP1 THSD7B LRP1B TG BCL11B CSMD1 LONRF2 MED27 AGBL1 | 4.78e-05 | 566 | 155 | 12 | EFO_0007660, EFO_0008354 |
| Disease | duodenal ulcer (implicated_via_orthology) | 8.20e-05 | 3 | 155 | 2 | DOID:1724 (implicated_via_orthology) | |
| Disease | liver disease | 1.63e-04 | 4 | 155 | 2 | EFO_0001421 | |
| Disease | serum gamma-glutamyl transferase measurement | CDKN1A KALRN PSD3 ITGA1 CSMD3 FAAP100 ZNF768 COLEC11 CELSR2 ZNF827 MICAL3 CSMD1 ALPK2 BAHCC1 | 3.47e-04 | 914 | 155 | 14 | EFO_0004532 |
| Disease | congestive heart failure (is_implicated_in) | 3.79e-04 | 27 | 155 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | pulse pressure measurement | CDKN1A BRPF3 PHF19 PCDHA11 ITGA1 SSPOP NEK9 STAT3 THBS2 CCN1 ZNF827 SLIT1 LRP1 CPXM1 LTBP3 ST18 TNS3 NPNT | 3.91e-04 | 1392 | 155 | 18 | EFO_0005763 |
| Disease | interstitial lung disease | 4.34e-04 | 67 | 155 | 4 | EFO_0004244 | |
| Disease | hereditary angioedema (is_implicated_in) | 5.66e-04 | 7 | 155 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | coronary artery disease | HBS1L VPS11 FAT4 PSD3 ITGA1 RNF114 NEK9 IGSF10 COLEC11 CELSR2 ZNF827 LRP1 C1R PLG TNS3 PARP12 | 5.71e-04 | 1194 | 155 | 16 | EFO_0001645 |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 7.52e-04 | 8 | 155 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | alcohol consumption measurement | RASA2 PAPLN THSD7B CSMD3 ADH1A MAGI2 BCL11B NSUN3 MICAL3 CSMD1 ST18 AGBL1 EP300 SEC23B PHLPP2 BAHCC1 | 8.67e-04 | 1242 | 155 | 16 | EFO_0007878 |
| Disease | substance abuse, antisocial behaviour measurement | 9.63e-04 | 9 | 155 | 2 | EFO_0007052, MONDO_0002491 | |
| Disease | alcohol use disorder measurement | 9.67e-04 | 214 | 155 | 6 | EFO_0009458 | |
| Disease | lactose measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0010507 | |
| Disease | glucagon-like peptide-1 measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0008465 | |
| Disease | Moyamoya disease | 1.22e-03 | 40 | 155 | 3 | MONDO_0016820 | |
| Disease | age at menarche | 1.23e-03 | 594 | 155 | 10 | EFO_0004703 | |
| Disease | Colorectal Carcinoma | KALRN PER1 BRINP1 PAK6 CSMD3 BCL11B LRP1 PRKD1 LONRF2 VWA2 EP300 | 1.26e-03 | 702 | 155 | 11 | C0009402 |
| Disease | glaucoma | 1.35e-03 | 154 | 155 | 5 | MONDO_0005041 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.37e-03 | 91 | 155 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | high grade glioma (is_implicated_in) | 1.40e-03 | 42 | 155 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | cognitive function measurement | SFMBT1 KALRN DBF4B PSD3 PER1 BRINP1 THSD7B CSMD3 LRP1B ADGRL4 THBS2 BCL11B PHLPP1 PRKD1 LONRF2 MED27 AGBL1 | 1.48e-03 | 1434 | 155 | 17 | EFO_0008354 |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.50e-03 | 43 | 155 | 3 | EFO_0022290 | |
| Disease | left ventricular systolic function measurement | 1.61e-03 | 44 | 155 | 3 | EFO_0008206 | |
| Disease | Malignant neoplasm of breast | MICAL1 KALRN NSD2 C1orf87 PER1 LAMA2 ECT2 STAT3 EGF WDCP TLL1 ABCB8 EP300 NOTCH4 | 1.64e-03 | 1074 | 155 | 14 | C0006142 |
| Disease | bronchopulmonary dysplasia | 1.72e-03 | 45 | 155 | 3 | MONDO_0019091 | |
| Disease | airway wall thickness measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0006898 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.75e-03 | 12 | 155 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 1.85e-03 | 523 | 155 | 9 | EFO_0005193 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.95e-03 | 47 | 155 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | JT interval | 2.05e-03 | 248 | 155 | 6 | EFO_0007885 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.06e-03 | 13 | 155 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | hip circumference | 2.13e-03 | 338 | 155 | 7 | EFO_0005093 | |
| Disease | aortic measurement | 2.17e-03 | 251 | 155 | 6 | EFO_0020865 | |
| Disease | fatty acid measurement | 2.22e-03 | 436 | 155 | 8 | EFO_0005110 | |
| Disease | facial width measurement | 2.32e-03 | 105 | 155 | 4 | EFO_0007855 | |
| Disease | dystonia (is_implicated_in) | 2.39e-03 | 14 | 155 | 2 | DOID:543 (is_implicated_in) | |
| Disease | erythrocyte measurement | 2.44e-03 | 257 | 155 | 6 | EFO_0005047 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.46e-03 | 51 | 155 | 3 | EFO_0022240 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.59e-03 | 447 | 155 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | body weight | SFMBT1 RASA2 JADE2 RTTN BRINP1 THSD7B PAK6 LRP1B BCL11B NSUN3 TLL1 SLIT1 DDX20 PRKD1 LTBP3 | 2.72e-03 | 1261 | 155 | 15 | EFO_0004338 |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.75e-03 | 53 | 155 | 3 | EFO_0022286 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.75e-03 | 15 | 155 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | non-alcoholic fatty liver disease | 2.80e-03 | 182 | 155 | 5 | EFO_0003095 | |
| Disease | pneumonia, COVID-19 | 3.03e-03 | 113 | 155 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Abnormality of refraction | 3.04e-03 | 673 | 155 | 10 | HP_0000539 | |
| Disease | vision disorder | 3.13e-03 | 16 | 155 | 2 | MONDO_0021084 | |
| Disease | 4-acetamidobutanoate measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0021003 | |
| Disease | T-Cell Lymphoma | 3.13e-03 | 16 | 155 | 2 | C0079772 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 3.13e-03 | 16 | 155 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | triglycerides in LDL measurement | 3.21e-03 | 56 | 155 | 3 | EFO_0022320 | |
| Disease | antihyperlipidemic drug use measurement | 3.22e-03 | 115 | 155 | 4 | EFO_0803367 | |
| Disease | psoriasis | 3.29e-03 | 273 | 155 | 6 | EFO_0000676 | |
| Disease | Carcinoma, Granular Cell | 3.33e-03 | 116 | 155 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.33e-03 | 116 | 155 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.33e-03 | 116 | 155 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.33e-03 | 116 | 155 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.33e-03 | 116 | 155 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.33e-03 | 116 | 155 | 4 | C0001418 | |
| Disease | Psoriasis | 3.38e-03 | 57 | 155 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 3.38e-03 | 57 | 155 | 3 | C0030246 | |
| Disease | heart disease (biomarker_via_orthology) | 3.54e-03 | 17 | 155 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.54e-03 | 17 | 155 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | lateral occipital cortex volume measurement | 3.54e-03 | 17 | 155 | 2 | EFO_0010311 | |
| Disease | acute kidney failure (is_marker_for) | 3.54e-03 | 17 | 155 | 2 | DOID:3021 (is_marker_for) | |
| Disease | triglycerides to total lipids in small LDL percentage | 3.73e-03 | 59 | 155 | 3 | EFO_0022337 | |
| Disease | age at first birth measurement | 3.75e-03 | 120 | 155 | 4 | EFO_0009101 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 3.91e-03 | 60 | 155 | 3 | EFO_0020690 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.09e-03 | 61 | 155 | 3 | DOID:3587 (is_marker_for) | |
| Disease | triglycerides in medium LDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022322 | |
| Disease | Congenital hernia of foramen of Morgagni | 4.42e-03 | 19 | 155 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 4.42e-03 | 19 | 155 | 2 | C0265700 | |
| Disease | glomerulonephritis (is_marker_for) | 4.42e-03 | 19 | 155 | 2 | DOID:2921 (is_marker_for) | |
| Disease | mood instability measurement | 4.72e-03 | 128 | 155 | 4 | EFO_0008475 | |
| Disease | RS-warfarin measurement | 4.72e-03 | 128 | 155 | 4 | EFO_0803325 | |
| Disease | parental longevity | 4.72e-03 | 494 | 155 | 8 | EFO_0007796 | |
| Disease | triglycerides in small LDL measurement | 4.89e-03 | 65 | 155 | 3 | EFO_0022323 | |
| Disease | polyunsaturated fatty acid measurement | 5.12e-03 | 131 | 155 | 4 | EFO_0010733 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDLKTVVPCCSGPKR | 361 | P21399 | |
| PCLPNAKCEIRNGIE | 26 | Q9HBW9 | |
| CPVCLPLKNAGDKRN | 411 | Q09472 | |
| PLGGKAPQACCTLDK | 511 | Q9P281 | |
| NPCGSKACRRLFGPV | 11 | P38936 | |
| CVNTGCGKPAVRPLV | 991 | Q9P2K9 | |
| PLPRCVAECGASVKG | 1096 | Q96PZ7 | |
| SLPTCIVPCGGILTK | 1931 | Q7Z407 | |
| LCQRPIPCVIGGNNS | 421 | O60477 | |
| IPLAIPQCGKCRICK | 91 | P07327 | |
| PKLLQDPCQKGTLGC | 1666 | Q86TB3 | |
| RPCPKGTRGIASFQC | 501 | O94910 | |
| GICREACQVPGPLFK | 406 | P18825 | |
| GAVGCIPLCPQELSL | 126 | O00622 | |
| DPSVKIGCRGPNICA | 4391 | Q6V0I7 | |
| VLCPQGKVCKAGSPA | 4471 | Q6V0I7 | |
| CQRLNCGVPLSLGPF | 81 | P06127 | |
| QGGAPCLRAEILACP | 261 | Q96SM3 | |
| PVDCILCPNKGGAFK | 266 | Q9ULD4 | |
| VPCPKGSVGNAVRHC | 2076 | Q9NYQ6 | |
| PRLRCQSCKLAQAPG | 141 | Q9HCU4 | |
| SPVQLKAIPLGRCGL | 86 | Q9UHI6 | |
| PLTTCGNLPFRRICK | 311 | Q96G46 | |
| VKPDLVLCNGPGTCV | 136 | Q96F25 | |
| PGTCVPICVSALLLG | 146 | Q96F25 | |
| KLCENCPSCPRILGL | 191 | Q9UPY3 | |
| LFCRAGGSIPIPQKL | 11 | P00736 | |
| CKIKDCGQPRNLPNG | 371 | P00736 | |
| CHGELCIIPAPRKSG | 141 | O95905 | |
| LPGGCSLVCKPSALA | 66 | Q6UXT9 | |
| VLCQTLGGNPCPLVT | 761 | Q96MI9 | |
| SGCLPLPKVRAICGK | 336 | Q8N0U7 | |
| LGCKPCTAGVPADIQ | 736 | Q15283 | |
| CRVIGPPVVLNCSQK | 146 | Q9H8V3 | |
| KINVGCIFCGPKVPI | 561 | Q9Y450 | |
| GIAPNLIRVTPACCI | 281 | Q9H2D1 | |
| VCSRCGQPVDPALLK | 71 | Q8IYY4 | |
| PFGPVINGRCCLEEK | 601 | Q9UM07 | |
| CAPGKPTLVCSRAVG | 731 | Q9Y5I1 | |
| CCVAPTNPRFGGKEL | 301 | Q14566 | |
| APGGKSIALLQCACP | 141 | Q9H649 | |
| RCLQLGACLQSSPPG | 191 | Q9NQU5 | |
| RCAPKVPNNCLGEVT | 311 | Q15139 | |
| NTKCLIIGAGPCGLR | 86 | Q7RTP6 | |
| KGPGNLNRPIFSKCC | 3056 | Q9NU22 | |
| KELQRVGPAACLCPG | 61 | Q8ND94 | |
| LLNPSGATCVCPEGK | 4186 | Q9NZR2 | |
| LTVRRKVLCGGEPCP | 856 | Q86UL8 | |
| RLNPAVTCAGKGTPL | 871 | Q8TD19 | |
| PGGLCIKNKTTCVPV | 91 | Q8NA97 | |
| KGQIRCQCPSPGLQL | 146 | Q6UXI9 | |
| ECEVLQGKGAPCRLP | 736 | Q17R60 | |
| LCPPGQTLLRDGKAC | 4781 | Q8NDA2 | |
| CPNGKRLDNGTCVPV | 4171 | Q07954 | |
| QILAGLCQRCGLPAP | 1371 | A9Z1Z3 | |
| KGDGTPRCSCPVHLV | 1231 | O75197 | |
| SALSKVCPGPGCLIR | 111 | Q8ND23 | |
| CALGVQPKCLLCPKR | 246 | Q9NQC1 | |
| RVSDGAPAQPCCLLI | 326 | O15534 | |
| QLCEKPGSLLLCEGP | 671 | O96028 | |
| QLRAKLKCPGGSCTP | 211 | Q5H8C1 | |
| DTVILQCKVCGRPKP | 2486 | O60229 | |
| IPHSCGEVCRKKQPG | 436 | Q12986 | |
| KILPGQAVCPTPGCR | 371 | Q8NA19 | |
| KCLVVGAGPCGLRVA | 86 | Q8TDZ2 | |
| RQGSKECPGCAQLAP | 161 | Q6X4W1 | |
| KTGRCICPPNTIGEK | 1026 | P24043 | |
| VGPLLLCTQCGPDGK | 1426 | Q9UMN6 | |
| LPCGLTVCKRCVEPG | 156 | Q1L5Z9 | |
| IPVDGCICPKGTFLD | 736 | P98088 | |
| CQRCGKFLQDGLPPT | 281 | Q6P2C8 | |
| KCPVGRGESLPCVKL | 81 | P56199 | |
| CPLGGLAAGKPRVLC | 16 | Q0VG06 | |
| LCAAGLPVCLTRAPK | 341 | Q86Y01 | |
| NITRIVSGCPLPEAC | 491 | Q9H0A0 | |
| PLRLCRAHQGSKPGC | 71 | Q9H0J9 | |
| PIGCLADRCKSGVPI | 256 | Q58A45 | |
| QTPCPLGAIRLKSLG | 171 | B2RXH4 | |
| AVLRCGPSPCGLLKQ | 256 | Q6UWH4 | |
| CTVRGCGKILPNSPA | 86 | O43313 | |
| AVICLVATPGGKACP | 16 | Q6WRI0 | |
| TRPRCAPKVLCAVGG | 276 | Q9NXS3 | |
| TKGICPKQENIAGPC | 131 | Q9C0K0 | |
| CIPISSCPQGKILNR | 336 | Q8N8U9 | |
| VCLLPPQCFKGGNQL | 881 | P13671 | |
| RCLGKKCVLNFPASP | 391 | Q9ULE3 | |
| RACCGRAVPLPGQKI | 126 | Q6EEV4 | |
| TCPVGFVLLPDGKRC | 381 | P01133 | |
| LPALPKGSREQGCLC | 431 | Q8NFT6 | |
| QQDGGPPKCCDLLRA | 71 | J3KSC0 | |
| NGEPGLPCECSQLRK | 106 | Q9BWP8 | |
| LGRCFQDTLPKQPCG | 276 | Q9NS15 | |
| VCLLCILGAPGQPVR | 11 | Q6UY11 | |
| LVNPTGLALCPKTGR | 126 | Q6VVB1 | |
| FPCLKKAQGGSRPRC | 286 | Q96QI5 | |
| PCNGNLVVSTGLCKP | 461 | P78385 | |
| SGRAPSCIPICGKIE | 436 | Q6UXH9 | |
| PLSGGCCVPKEQLRG | 456 | Q9NUT2 | |
| TCPLCRKVTAVPGGL | 81 | Q9NXI6 | |
| NDRLSLKGCPGPCGV | 1101 | Q86VV8 | |
| ASCCAVVPVLDKLGP | 221 | O95397 | |
| NCPACQGPLTKTKGI | 291 | Q7L3T8 | |
| FGGAPCPETVQRKKC | 701 | Q9HCB6 | |
| LLPPQELCRKGGFCE | 241 | Q6NUJ1 | |
| CVNPCSVTLLVKGPN | 366 | Q92526 | |
| VKALPLQAAGCTGRP | 521 | Q16650 | |
| RKPGFCERLCPGGQL | 461 | A2VEC9 | |
| GRLCGNKIPDPLVAT | 846 | O43897 | |
| LLACCPGDQKPGILA | 71 | Q6ZMZ3 | |
| QGGPKTCCTLDDVPL | 51 | Q86TG1 | |
| PNGCKCLGPERVAQL | 1301 | Q8NDG6 | |
| NLCVCGALMRPLSPG | 201 | Q7RTX9 | |
| CRFKVPTLKLNIPGC | 626 | Q9H0K6 | |
| SLKVVPRVGNGTLCP | 21 | Q8WVE7 | |
| LRKRLGSLCCAPQGG | 366 | Q8NGU9 | |
| CCGLLRQRPQKPAAL | 981 | Q14524 | |
| LKGSAITRQPAGLCP | 111 | P0DH78 | |
| PKCIRCAVVGNGGIL | 146 | Q9UJ37 | |
| VVRGLCGPAIGKLCE | 91 | A6NNN8 | |
| GVEPIGPRVKCCLEV | 396 | A6NNN8 | |
| CTPKGVRLKGCSNEP | 1241 | Q68CZ2 | |
| QVEPKKCPGRVVGGC | 571 | P00747 | |
| KCLPGFEGPRCQTEV | 576 | Q99466 | |
| LPRCRQVGDHGKPCV | 201 | Q86UD1 | |
| AIGPCVSLNVKGPCV | 421 | Q15437 | |
| HENVLKCPTPGCTGR | 406 | O60284 | |
| GSPEKRCPGGVLSCI | 536 | Q02040 | |
| PPKGRILLDGCTITC | 46 | Q9NYT0 | |
| KFLCLPPGITVCDSG | 41 | Q9H270 | |
| CQAVLCRGGKPVPLS | 901 | Q6ZVD8 | |
| KPVCGVCRSALAPGV | 61 | Q9Y508 | |
| CIPPTGQRVRSGEKC | 716 | Q7RTY8 | |
| GKPPAIQACNLQRCA | 411 | O95428 | |
| RQQIACIGGPPNICL | 246 | P40763 | |
| RKRGLCVLCGLPAAG | 16 | Q8IV42 | |
| QKAVGVQCPVCREPL | 191 | Q96BH1 | |
| LIQFPRKLLCGLCPG | 501 | Q7Z404 | |
| AVVAQKPGAGCPSRC | 26 | Q92626 | |
| QGPRPNICGICGKSF | 256 | Q9H5H4 | |
| PELQGKLCSRQRPGC | 511 | Q5GFL6 | |
| EPKCNICLGKTSGPL | 96 | Q5T6S3 | |
| RLPVACPNQCGVGTV | 216 | Q9BUZ4 | |
| CPVCKAGISRDKVIP | 76 | Q96GF1 | |
| QVSPCQGRRCFPKAL | 21 | Q13336 | |
| QKVPEGGCSLPCEFR | 1281 | Q9P2E3 | |
| GKPFQCPICGLVIKR | 371 | Q17R98 | |
| NCGLLVSLGCPVPKA | 46 | O43296 | |
| QGEKPAQCTPCGKRS | 291 | Q8N393 | |
| IFCCTLRLPPVKRGQ | 181 | Q7Z5H4 | |
| CQTVLCRNGKPLPLS | 1291 | O60346 | |
| RIAELPQCVGPGNCV | 521 | Q9UHJ3 | |
| PQCVGPGNCVLVLRE | 526 | Q9UHJ3 | |
| PTQAKGLCGSCNKPI | 221 | O43294 | |
| LFAPRCQGCQGPILD | 341 | O43294 | |
| LCAPLRKCRPGFGVA | 136 | P20333 | |
| RETKACQGAPCPIDG | 481 | P35442 | |
| PQQVLETRPCTGGKC | 1416 | Q9C0I4 | |
| CEIRGSLPILPQGCV | 106 | Q9H6R7 | |
| GSACCGRNPQFPKLV | 296 | Q9BXE9 | |
| GPPTLAVQAKCDLCL | 916 | O75093 | |
| PGRPVACLSFCQLQK | 86 | P01266 | |
| GRKGAVCVQEPSCPL | 236 | Q9NYI0 | |
| AQTALPCDICGPILK | 46 | P52741 | |
| RVRKPRCCTGPQGLL | 4226 | Q5THJ4 |